SARS: a model disease(e global spread of the disease. Th...),Health
Navigation Links
SARS: a model disease
Date:11/20/2007
e global spread of the disease.
"The presented computational approach shows that the integration of long-range mobility and demographic data provides epidemic models with a predictive power that can be consistently tested," the researchers explain. "This computational strategy can be therefore considered as a general tool in the analysis and forecast of the global spreading of emerging diseases."
'/>"/>
| Contact: Charlotte Webber press@biomedcentral.com 44-020-763-19980 BioMed Central Source:Eurekalert |
Related medicine news :
1. Chromatin remodeling complex connected to DNA damage control
2. Health care incentive model offers collaborative approach
3. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
4. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
5. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
6. New knock-out gene model provides molecular clues to breast cancer
7. Rain Man mice provide model for autism
8. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
9. USC researcher identifies stem cells in tendons that regenerate tissue in animal model
10. Americas Next Top Model Steps up for Psoriasis Awareness
11. Computer models help raise the bar for sporting achievement
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:Pitt study suggests craving hinders comprehension without your realizing it 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:Wellness Cruise Offers Crystal Guests 'Indian Ocean Insight' 2
[0] Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs[0] Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765[0] Pitt study suggests craving hinders comprehension without your realizing it[0] City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans[1] Wellness Cruise Offers Crystal Guests 'Indian Ocean Insight'
Other Medicine News:Health News:Compensation Demanded For Bengal's Blood Scam Victims 2Health News:Indian radiologist spearheads cure for osteoarthritis sans surgery 2Health News:Indian radiologist spearheads cure for osteoarthritis sans surgery 3Health News:Cialis- Bringing Respite To ED Effectively 2Health News:Fighting cancer - Multiple Myeloma with long-term therapy 2
Compensation Demanded For Bengal's Blood Scam VictimsIndian radiologist spearheads cure for osteoarthritis sans surgeryCialis- Bringing Respite To ED EffectivelyUS calls 'interrogation techniques' national security secretsFighting cancer - Multiple Myeloma with long-term therapyIndia, a Hot Destination? Software or Sex, Indians are the Best!
Breaking Medicine Technology:Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7President Announces Free Health Plan 58446 1President Announces Free Health Plan 58446 2President Announces Free Health Plan 58446 3Crisis in Aging 3A Disability and Alzheimer 26apos 3Bs 3A Lack of Caregivers Threatens South Florida Seniors 26apos 3B Ability to Stay Home 58441 1Crisis in Aging 3A Disability and Alzheimer 26apos 3Bs 3A Lack of Caregivers Threatens South Florida Seniors 26apos 3B Ability to Stay Home 58441 2Crisis in Aging 3A Disability and Alzheimer 26apos 3Bs 3A Lack of Caregivers Threatens South Florida Seniors 26apos 3B Ability to Stay Home 58441 3Crisis in Aging 3A Disability and Alzheimer 26apos 3Bs 3A Lack of Caregivers Threatens South Florida Seniors 26apos 3B Ability to Stay Home 58441 4Scientists find obesity alone does not cause arthritis in animals 58436 1Scientists find obesity alone does not cause arthritis in animals 58436 2Scientists find obesity alone does not cause arthritis in animals 58436 3
[0] Royalty Pharma Announces that Alexander von Perfall Joins Management Team[0] ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program[0] Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
Other Medicine Technology:Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 2Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 3Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 4Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 5Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders 2Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |